Complete Filing Data
Tiziana Life Sciences Ltd reported Cash And Cash Equivalents of $3.72 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Tiziana Life Sciences Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $5.2M | $8.1M | $13.0M | $13.2M | $6.0M | $3.7M | $5.5M | $6.0M | $4.0M |
| Profit Loss From Operating Activities | -$15.8M | -$18.0M | -$14.6M | -$27.4M | -$28.0M | -$9.9M | -$9.9M | -$10.5M | -$9.9M |
| Profit Loss Before Tax | -$16.7M | -$17.2M | -$15.4M | -$26.7M | -$28.3M | -$10.0M | -$9.9M | -$10.5M | -$9.9M |
| Profit Loss | -$11.9M | -$17.7M | -$15.4M | -$23.4M | -$26.1M | -$9.3M | -$7.9M | -$8.6M | -$9.8M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$72.0K | $1.5M | -$3.6M | -$4.5M | $3.5M | -$27.0K | -$21.0K | $61.0K | $650.0K |
| Comprehensive Income | -$11.9M | -$16.2M | -$19.0M | -$27.9M | -$22.7M | -$9.4M | -$8.0M | -$8.5M | -$9.1M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation1 | -$72.0K | $1.5M | -$3.6M | -$4.5M | $3.5M | -$27.0K | -$21.0K | $61.0K | $650.0K |
| Profit Loss1 | -$15.4M | -$23.4M | -$26.1M | -$9.3M | -$7.9M | -$8.6M | -$9.8M | ||
| Comprehensive Income1 | -$19.0M | $27.9M | -$22.7M | -$9.4M | -$8.0M | -$8.5M | -$9.1M | ||
| Adjustments For Interest Expense | $163.0K | $272.0K | $50.0K | $12.0K | $12.0K | $12.0K | |||
| Total Operating Expenses | -$14.6M | -$27.4M | -$28.0M | -$9.9M | -$9.9M | -$10.5M | |||
| Income Tax S Credit | -$4.9M | $449.0K | -$3.2M | -$2.2M | -$689.0K | ||||
| Income Taxes Paid Refund Classified As Operating Activities | -$490.0K | -$1.4M | -$1.0M | -$2.8M | |||||
| Income Tax Expense Continuing Operations | -$2.2M | -$689.0K | -$1.9M | -$1.9M | -$121.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $3.7M | $1.2M | $18.1M | $42.2M | $65.8M | $200.0K | $5.3M | $64.0K | $5.8M | $13.1M |
| Cash Flows From Used In Financing Activities | $4.5M | $40.0K | -$55.0K | -$23.0K | $75.3M | $1.7M | $10.1M | $1.5M | $1.6M | |
| Cash Flows From Used In Operating Activities | -$1.5M | -$15.7M | -$19.6M | -$21.8M | -$11.3M | -$6.8M | -$4.6M | -$7.5M | ||
| Cash Flows From Used In Investing Activities | -$71.0K | -$1.3M | -$4.0M | $130.0K | -$123.0K | -$4.0K | -$1.0K | -$342.0K | ||
| Adjustments For Increase Decrease In Other Liabilities | $839.0K | -$138.0K | $347.0K | -$516.0K | -$972.0K | -$23.0K | $2.0M | $2.3M | ||
| Adjustments For Decrease Increase In Other Operating Receivables | $78.0K | $80.0K | $1.0M | $516.0K | -$437.0K | $159.0K | -$180.0K | $54.0K | ||
| Repayment Of Leasing Liabilities | -$141.0K | -$119.0K | -$55.0K | -$152.0K | -$277.0K | -$200.0K | ||||
| Net Increase In Related Party Receivables | $1.5M | $1.5M | $1.2M | $88.0K | $31.0K | $287.0K | ||||
| Retained Earnings | -$144.8M | -$133.7M | -$116.3M | -$108.1M | -$84.6M | -$60.0M | -$50.7M | -$42.6M | ||
| Property Plant And Equipment | $16.0K | $10.0K | $17.0K | $17.0K | $3.0K | $6.0K | $7.0K | $23.0K | ||
| Prepaymentsand Other Receivables Current | $145.0K | $223.0K | $300.0K | $1.3M | $785.0K | $165.0K | $567.0K | $2.4M | ||
| Noncurrent Assets | $3.8M | $4.8M | $2.2M | $147.0K | $480.0K | $873.0K | $7.0K | $23.0K | ||
| Net Increase In Related Party Payables | $1.4M | $685.0K | $1.1M | $436.0K | $144.0K | |||||
| Liabilities | $7.3M | $6.6M | $6.9M | $7.5M | $8.3M | $7.9M | $6.4M | $4.7M | ||
| Equity And Liabilities | $11.3M | $12.2M | $26.5M | $48.8M | $70.7M | $2.4M | $6.9M | $2.5M | ||
| Current Liabilities | $7.3M | $6.5M | $6.7M | $7.5M | $8.0M | $7.4M | $6.4M | $4.7M | ||
| Current Assets | $7.5M | $7.3M | $24.3M | $48.7M | $70.2M | $1.5M | $6.9M | $2.4M | ||
| Assets | $11.3M | $12.2M | $26.5M | $48.8M | $70.7M | $2.4M | $6.9M | $2.5M | ||
| Taxation Receivable | $32.0K | $3.8M | $4.2M | $4.7M | $3.0M | $675.0K | $1.0M | |||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $19.0K | $22.0K | $3.0K | $4.0K | $1.0K | $48.0K | ||||
| Amounts Receivable Related Party Transactions | $3.6M | $2.1M | $1.6M | $456.0K | $368.0K | $322.0K | $24.0K | |||
| Issue Of Equity | $1.8M | -$1.3M | $761.0K | $71.2M | $106.0K | $10.0M | $1.5M | $630.0K | ||
| Current Lease Liabilities | $106.0K | $138.0K | $122.0K | $265.0K | $279.0K | $260.0K | ||||
| Rightofuse Assets | $171.0K | $283.0K | $372.0K | $357.0K | $433.0K | |||||
| Accounts Payable And Accrued Expenses Current | $6.5M | $6.2M | $5.6M | $6.4M | $6.0M | $4.7M | ||||
| Noncurrent Lease Liabilities | $109.0K | $243.0K | $290.0K | $541.0K | $839.0K | |||||
| Other Liabilities | $9.0K | $10.0K | $85.0K | $82.0K | ||||||
| Bonus To Be Settled In Equity | $100.0K | $855.0K | $13.5M | |||||||
| Gains Losses On Disposals Of Investments | -$1.8M | -$402.0K | -$869.0K | |||||||
| Amounts Payable Related Party Transactions | $1.4M | $1.7M | $594.0K | $447.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | $2.9M | -$16.9M | -$23.7M | -$21.7M | $63.9M | -$5.1M | $5.5M | -$6.0M | -$5.7M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$367.0K | -$28.0K | -$398.0K | -$2.0M | $1.7M | $16.0K | -$249.0K | $254.0K | -$1.6M |
| Proceeds From Issuance Of Warrant | $129.0K | $3.4M | $1.5M | ||||||
| Proceeds From Issuance Of Options | $135.0K | $129.0K | $939.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Basic Earnings Loss Per Share | $-0.11 | $-0.17 | $-0.15 | $-0.24 | $-0.16 | $-0.07 | $-0.06 |
| Diluted Earnings Loss Per Share | $-0.11 | $-0.17 | $-0.15 | $-0.24 | $-0.16 | ||
| Shares Issued In Lieu Of Fees | 1.8M | 425.0K | 466.0K | 105.0K | 55.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Finance Income Cost | $814.0K | $1.1M | -$7.0K | -$176.0K | -$312.0K | -$91.0K | -$12.0K | -$12.0K | -$12.0K |
| Adjustments For Depreciation Expense | $12.0K | $7.0K | $1.0K | $8.0K | $5.0K | $5.0K | $16.0K | $13.0K | $11.0K |
| Increase Decrease Through Transactions With Owners | $10.3M | $2.2M | -$1.4M | $6.8M | $15.4M | $3.2M | $10.8M | $2.2M | -$669.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$158.0K | -$1.5M | $3.2M | $1.9M | -$237.0K | -$165.0K | $296.0K | $45.0K | |
| Depreciation Of Rightofuse Asset | $112.0K | $89.0K | $50.0K | $133.0K | $86.0K | $248.0K | |||
| Other Operating Income Expense | $65.0K | $893.0K | -$11.2M | -$6.2M | -$4.4M | -$4.5M | |||
| Adjustments For Sharebased Payments Warrants | $1.7M | $1.8M | $1.8M | $5.2M | $26.0K | $60.0K | $171.0K | $121.0K | |
| Reserve Of Sharebased Payments | $7.6M | $6.9M | $5.2M | $13.8M | $8.6M | $5.2M | $3.9M | $3.2M | |
| Reserve Of Exchange Differences On Translation | -$1.7M | -$1.6M | -$3.1M | $454.0K | $5.4M | $1.9M | $2.0M | $2.0M | |
| Other Reserves | $118.7M | $118.7M | $118.7M | $118.7M | $118.7M | -$46.2M | -$46.2M | -$46.2M | |
| Other Gains Losses | -$952.0K | $742.0K | -$811.0K | $717.0K | -$312.0K | -$91.0K | |||
| Issued Capital | $111.0K | $103.0K | $102.0K | $102.0K | $97.0K | $8.6M | $8.6M | $8.1M | |
| Share Premium | $23.1M | $16.5M | $15.6M | $15.6M | $111.8M | $39.9M | $39.8M | $31.3M | |
| Share Capital Outstanding | $111.5M | $103.1M | $102.3M | $102.3M | $97.3M | $136.5M | $136.5M | ||
| Share Based Paymentoptions | $1.7M | $1.8M | $1.8M | $5.2M | $5.1M | $1.3M | |||
| Issuance Of Share Capital | $111.5M | $103.1M | $102.3M | $102.3M | $97.3M | $136.5M | $136.5M | ||
| Share Based Payment Reserve Warrants | $25.0K | $697.0K | $697.0K | $697.0K | $2.4M | $1.9M | $579.0K | ||
| Options Forfeitedcancelled | -$167.0K | -$39.0K | -$3.2M | -$35.0K | |||||
| Operating Expense | $15.8M | $18.0M | $14.6M | $27.4M | $9.9M | $10.6M | $9.9M | ||
| Fundraising Cost | $124.0K | $24.0K | $71.2M | $8.6M | |||||
| Adjustments For Forfeiture Of Options | $1.8M | $5.2M | $5.1M | -$1.3M | -$672.0K | ||||
| Purchase Of Treasury Amount | $52.0K | $253.0K | $1.3M | ||||||
| Options Forfeited During The Year | $227.0K | $39.0K | $3.2M | ||||||
| Increase Decrease Through Exercise Of Options | -$80.0K | $1.3M | $641.0K | $1.3M | $1.1M | ||||
| FV Loss On Investment | $1.8M | $402.0K | $869.0K | ||||||
| Other Expense By Function | $10.6M | $9.9M | $1.6M | $13.3M | |||||
| Realisation Bonus | $855.0K | $13.2M | |||||||
| Investment In Related Party | $1.0M | $2.7M |
Most recent annual filing with the SEC: May 6, 2025
Data sourced from SEC EDGAR public filings as of August 10, 2026.